Infectious Disease Molecular Diagnostics Market Size, Share & Trends Report

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-4-68039-529-7
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2024
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Segmentation 

  • Infectious Disease Molecular Diagnostics  Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Instruments
    • Reagents
    • Services
  • Infectious Disease Molecular Diagnostics  Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • Polymerase Chain Reaction (PCR)
      • Multiplex PCR
        • Instruments
        • Reagents
        • Others
      • Other PCR
    • In Situ Hybridization
      • Instruments
      • Reagents
      • Services
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Instruments
      • Reagents
      • Services
    • Chips and Microarrays
      • Instruments
      • Reagents
      • Services
    • Mass Spectrometry
      • Instruments
      • Reagents
      • Services
    • Transcription Mediated Amplification
      • Instruments
      • Reagents
      • Services
    • Others
      • Instruments
      • Reagents
      • Services
  • Infectious Disease Molecular Diagnostics  Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infections
    • Sepsis
    • Drug Resistance Diseases
    • Others
  • Infectious Disease Molecular Diagnostics  End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Infectious Disease Molecular Diagnostics  Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Instruments
        • Reagents
        • Services
      • North America Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Polymerase Chain Reaction (PCR)
          • Multiplex PCR
            • Instruments
            • Reagents
            • Others
          • Other PCR
        • In Situ Hybridization
          • Instruments
          • Reagents
          • Services
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
          • Instruments
          • Reagents
          • Services
        • Chips and Microarrays
          • Instruments
          • Reagents
          • Services
        • Mass Spectrometry
          • Instruments
          • Reagents
          • Services
        • Transcription Mediated Amplification
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • North America Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Respiratory Diseases
        • Tuberculosis
        • Meningitis
        • Gastrointestinal Tract Infections
        • HPV
        • Sexually Transmitted Infections
        • Sepsis
        • Drug Resistance Diseases
        • Others
      • North America End use Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Clinics
        • Diagnostics Laboratories
        • Research Institutes
      • U.S.
        • U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • U.S. Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • U.S. End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Canada
        • Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Canada Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Canada End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Mexico
        • Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Mexico Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Mexico End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
    • Europe
      • Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Instruments
        • Reagents
        • Services
      • Europe Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Polymerase Chain Reaction (PCR)
          • Multiplex PCR
            • Instruments
            • Reagents
            • Others
          • Other PCR
        • In Situ Hybridization
          • Instruments
          • Reagents
          • Services
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
          • Instruments
          • Reagents
          • Services
        • Chips and Microarrays
          • Instruments
          • Reagents
          • Services
        • Mass Spectrometry
          • Instruments
          • Reagents
          • Services
        • Transcription Mediated Amplification
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Respiratory Diseases
        • Tuberculosis
        • Meningitis
        • Gastrointestinal Tract Infections
        • HPV
        • Sexually Transmitted Infections
        • Sepsis
        • Drug Resistance Diseases
        • Others
      • Europe End use Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Clinics
        • Diagnostics Laboratories
        • Research Institutes
      • UK
        • UK Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • UK Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • UK Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • UK End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Germany
        • Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Germany Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Germany End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • France
        • France Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • France Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • France Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • France End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Italy
        • Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Italy Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Italy End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Spain
        • Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Spain Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Spain End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Denmark
        • Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Denmark Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Denmark End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Sweden
        • Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Sweden Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Sweden End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Norway
        • Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Norway Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Norway End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
    • Asia Pacific
      • Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Instruments
        • Reagents
        • Services
      • Asia Pacific Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Polymerase Chain Reaction (PCR)
          • Multiplex PCR
            • Instruments
            • Reagents
            • Others
          • Other PCR
        • In Situ Hybridization
          • Instruments
          • Reagents
          • Services
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
          • Instruments
          • Reagents
          • Services
        • Chips and Microarrays
          • Instruments
          • Reagents
          • Services
        • Mass Spectrometry
          • Instruments
          • Reagents
          • Services
        • Transcription Mediated Amplification
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Respiratory Diseases
        • Tuberculosis
        • Meningitis
        • Gastrointestinal Tract Infections
        • HPV
        • Sexually Transmitted Infections
        • Sepsis
        • Drug Resistance Diseases
        • Others
      • Asia Pacific End use Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Clinics
        • Diagnostics Laboratories
        • Research Institutes
      • China
        • China Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • China Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • China Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • China End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Japan
        • Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Japan Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Japan End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • India
        • India Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • India Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • India Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • India End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Australia
        • Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Australia Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Australia End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • South Korea
        • South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • South Korea Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • South Korea End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Thailand
        • Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Thailand Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Thailand End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
    • Latin America
      • Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Instruments
        • Reagents
        • Services
      • Latin America Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Polymerase Chain Reaction (PCR)
          • Multiplex PCR
            • Instruments
            • Reagents
            • Others
          • Other PCR
        • In Situ Hybridization
          • Instruments
          • Reagents
          • Services
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
          • Instruments
          • Reagents
          • Services
        • Chips and Microarrays
          • Instruments
          • Reagents
          • Services
        • Mass Spectrometry
          • Instruments
          • Reagents
          • Services
        • Transcription Mediated Amplification
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Respiratory Diseases
        • Tuberculosis
        • Meningitis
        • Gastrointestinal Tract Infections
        • HPV
        • Sexually Transmitted Infections
        • Sepsis
        • Drug Resistance Diseases
        • Others
      • Latin America End use Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Clinics
        • Diagnostics Laboratories
        • Research Institutes
      • Brazil
        • Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Brazil Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Brazil End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Argentina
        • Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Argentina Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Argentina End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
    • Middle East and Africa (MEA)
      • MEA Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Instruments
        • Reagents
        • Services
      • MEA Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Polymerase Chain Reaction (PCR)
          • Multiplex PCR
            • Instruments
            • Reagents
            • Others
          • Other PCR
        • In Situ Hybridization
          • Instruments
          • Reagents
          • Services
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
          • Instruments
          • Reagents
          • Services
        • Chips and Microarrays
          • Instruments
          • Reagents
          • Services
        • Mass Spectrometry
          • Instruments
          • Reagents
          • Services
        • Transcription Mediated Amplification
          • Instruments
          • Reagents
          • Services
        • Others
          • Instruments
          • Reagents
          • Services
      • MEA Application Outlook (Revenue, USD Million, 2018 - 2030)
        • Respiratory Diseases
        • Tuberculosis
        • Meningitis
        • Gastrointestinal Tract Infections
        • HPV
        • Sexually Transmitted Infections
        • Sepsis
        • Drug Resistance Diseases
        • Others
      • MEA End use Outlook (Revenue, USD Million, 2018 - 2030)
        • Hospitals
        • Clinics
        • Diagnostics Laboratories
        • Research Institutes
      • South Africa
        • South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • South Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • South Africa End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Saudi Arabia
        • Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Saudi Arabia Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Saudi Arabia End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • UAE
        • UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • UAE Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • UAE End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes
      • Kuwait
        • Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Instruments
          • Reagents
          • Services
        • Kuwait Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Polymerase Chain Reaction (PCR)
            • Multiplex PCR
              • Instruments
              • Reagents
              • Others
            • Other PCR
          • In Situ Hybridization
            • Instruments
            • Reagents
            • Services
          • Isothermal Nucleic Acid Amplification Technology (INAAT)
            • Instruments
            • Reagents
            • Services
          • Chips and Microarrays
            • Instruments
            • Reagents
            • Services
          • Mass Spectrometry
            • Instruments
            • Reagents
            • Services
          • Transcription Mediated Amplification
            • Instruments
            • Reagents
            • Services
          • Others
            • Instruments
            • Reagents
            • Services
        • Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
          • Respiratory Diseases
          • Tuberculosis
          • Meningitis
          • Gastrointestinal Tract Infections
          • HPV
          • Sexually Transmitted Infections
          • Sepsis
          • Drug Resistance Diseases
          • Others
        • Kuwait End use Outlook (Revenue, USD Million, 2018 - 2030)
          • Hospitals
          • Clinics
          • Diagnostics Laboratories
          • Research Institutes

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon